Evidence map›Paper›PMID 27890918›Full record

ArticleActa pharmacologica Sinica2017

2-Hydroxy-3-methoxybenzoic acid attenuates mast cell-mediated allergic reaction in mice via modulation of the FcεRI signaling pathway.

Yeon-Yong Kim, In-Gyu Je, Min Jong Kim, Byeong-Cheol Kang, Young-Ae Choi, Moon-Chang Baek, Byungheon Lee, Jin Kyeong Choi, Hae Ran Park, Tae-Yong Shin and 5 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ethanol Extract ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Yeon-Yong KimCMRI, Department of Pharmacology, Daegu 700-422, Republic of Korea.
In-Gyu JeCMRI, Department of Pharmacology, Daegu 700-422, Republic of Korea.
Min Jong KimCMRI, Department of Pharmacology, Daegu 700-422, Republic of Korea.
Byeong-Cheol KangCMRI, Department of Pharmacology, Daegu 700-422, Republic of Korea.
Young-Ae ChoiCMRI, Department of Pharmacology, Daegu 700-422, Republic of Korea.
Moon-Chang BaekDepartment of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea.
Byungheon LeeResearch Laboratories, ILDONG Pharmaceutical Co Ltd, Hwaseong 18449, Republic of Korea.
Jin Kyeong ChoiCMRI, Department of Pharmacology, Daegu 700-422, Republic of Korea.
Hae Ran ParkCollege of Pharmacy, Woosuk University, Jeonju 565-701, Republic of Korea.
Tae-Yong ShinCollege of Pharmacy, Woosuk University, Jeonju 565-701, Republic of Korea.
Soyoung LeeNatural Product Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 580-185, Republic of Korea.
Seung-Bin YoonNational Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang 28116, Republic of Korea.
Sang-Rae LeeNational Primate Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang 28116, Republic of Korea.
Dongwoo KhangDepartment of Molecular Medicine, School of Medicine, Gachon University, Incheon 406-840, Republic of Korea.
Sang-Hyun KimCMRI, Department of Pharmacology, Daegu 700-422, Republic of Korea.
Korea Research Institute of Bioscience and Biotechnology · KRWoosuk University · KRDaewoong Pharmaceutical (South Korea) · KRGachon University · KRKyungpook National University · KRNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mast cells are important effector cells in immunoglobulin (Ig) E-mediated allergic reactions such as asthma, atopic dermatitis and rhinitis. Vanillic acid, a natural product, has shown anti-oxidant and anti-inflammatory activities. In the present study, we investigated the anti-allergic inflammatory effects of ortho-vanillic acid (2-hydroxy-3-methoxybenzoic acid, o-VA) that was a derivative of vanillic acid isolated from Amomum xanthioides. In mouse anaphylaxis models, oral administration of o-VA (2, 10, 50 mg/kg) dose-dependently attenuated ovalbumin-induced active systemic anaphylaxis and IgE-mediated cutaneous allergic reactions such as hypothermia, histamine release, IgE production and vasodilation; administration of o-VA also suppressed the mast cell degranulator compound 48/80-induced anaphylaxis. In cultured mast cell line RBL-2H3 and isolated rat peritoneal mast cells in vitro, pretreatment with o-VA (1-100 μmol/L) dose-dependently inhibited DNP-HSA-induced degranulation of mast cells by decreasing the intracellular free calcium level, and suppressed the expression of pro-inflammatory cytokines TNF-α and IL-4. Pretreatment of RBL-2H3 cells with o-VA suppressed DNP-HSA-induced phosphorylation of Lyn, Syk, Akt, and the nuclear translocation of nuclear factor-κB. In conclusion, o-VA suppresses the mast cell-mediated allergic inflammatory response by blocking the signaling pathways downstream of high affinity IgE receptor (FcεRI) on the surface of mast cells.

Indexed as

AnaphylaxisAnimalsBenzoatesCalciumCell DegranulationCells, CulturedDinitrophenolsDose-Response Relationship, DrugHypersensitivityImmunoglobulin EInflammation MediatorsMaleMast CellsMiceNF-kappa BOvalbumin2-hydroxy-3-methoxybenzoic acidBenzoatesCalciumDinitrophenolsdinitrophenyl-human serum albumin conjugateFCER1A protein, ratImmunoglobulin EInflammation MediatorsNF-kappa BOvalbuminp-Methoxy-N-methylphenethylamineReceptors, IgESerum AlbuminVanillic Acid

Identifiers

PMID27890918
PMCPMC5220539
OpenAlexW2558597122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.